Recommended

New webinar with Fujifilm: Monocyte activation test (MAT): Insight into examining regulations and markets prospects
New webinar: The path to optimisation in pharmaceutical microbiology
Join our webinar: An alternative medium to support sterility testing using the Growth Direct® Rapid Sterility System
Discover more in our new application note: validating recombinant cascade reagents in 3 simple steps

List view / Grid view

Catalent

 

vials of liquid for injection being labelled on a production line
vials of liquid for injection being labelled on a production line
article

Sterile and antiviral packaging: unlocking the potential of business continuity and resilience during COVID-19 pandemic

6 May 2020 | By ,

Amid the disruptions due to COVID-19, companies providing sterile and antiviral packaging solutions look forward to opportunities arising from the concern over viral exposure itself. Regulatory compliance will play a significant role in the rapidly shifting risk terrain.

21st anniversary edition
21st anniversary edition
article

21st Anniversary Supplement

21 December 2017 | By

European Pharmaceutical Review has brought you the most up-to-date and relevant pharmaceutical science for the past 21 years. This anniversary supplement brings you a selection of topical views from across the industry, reviewing progress over that time, as well as looking to the future.

Continuous-manufacturing-machine
Continuous-manufacturing-machine
article

Continuous manufacturing: regulatory and quality assurance challenges

22 August 2017 | By , ,

During 2002, the United States Food and Drug Administration (FDA) requested rationalisation and modernisation of the manufacturing base for pharmaceutical production. This was in the hope that modernising the supply chain would enhance the robustness of manufacturing processes, thereby reducing product failures and, importantly, significantly enhancing product quality.1 The FDA’s…

Paul Wituschek, Catalent
Paul Wituschek, Catalent
news

Antibody Drug Conjugates (ADC)

19 February 2014 | By Paul Wituschek, Vice President of Sales, Development and Clinical Services, Catalent

Paul Wituschek, Vice President of Sales, Development and Clinical Services, Catalent answers the question: "Other than oncology, for which disease areas do you see Antibody Drug Conjugates (ADC) being used extensively in the future?"

Dr David Igo, Director of Product Development and Manufacturing at Catalent
Dr David Igo, Director of Product Development and Manufacturing at Catalent
product

Catalent presents at AAPS 2013

22 November 2013 | By Freddy White, European Pharmaceutical Review

Dr David Igo, Director of Product Development and Manufacturing at Catalent, presents their new FormProRx™ Web Tool to Freddy White at AAPS 2013.

article

Industry Expert Panel

21 February 2013 | By

Welcome to European Pharmaceutical Review’s Industry Expert Panel. We have assembled a panel of authoritative voices from the pharmaceutical industry to speak on a wide range of issues that affect this industry, sharing their expertise and insight with our readers.